How has cannabis helped treat your medical condition?4:20
CBD, along with THC, is currently at the forefront of the medical medication discussion and for very good reason. With the legal cannabis market expected to grow to $37 billion USD by the end of 2023 (1), a majority of that financial promise lies within the medicinal aspects of the plant. Cannabidiol, better known as CBD, is revered in regard to treating epileptic seizures and that’s only a partial reason for its present-day booming popularity.
There has always been evidence of CBD helping, but more clinical trials certainly need to be funded and completed. In 1980, a double-blind study consisting of 15 patients suffering from secondary generalized epilepsy with temporal focus were divided into two groups (2). One group was given 200-300mg daily of CBD and the other, a placebo – the study lasted for 4 and a half months with the patients continuing to use prior prescribed antiepileptic drugs the entire time. The results of this study dawning 39 years ago found that 4 of the 8 CBD patients remained free of convulsive episodes, 3 patients improved partially and 1 reported inefficacy altogether. Strong promise is what was shown, and that’s more than enough reason for medical cannabis research to be rewarded with as much funding necessary to continue making strides.
Let’s fast forward to the 2010s, a report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy in 2013 surfaced with a more decisive view on the matter (3). This survey was presented to parents belonging to a Facebook group in strong support of sharing CBD information which they used to treat their child’s seizures stemming from childhood epilepsy. Nineteen responses met the criteria for the study and were analyzed thoroughly; 84% of the 19 parents participating reported a reduction in their child’s seizure frequency while taking CBD prominent cannabis. Of that 84%, 11% of the parents reported complete seizure freedom and eight parents (42%) reported a greater than 80% reduction in seizure frequency.
As the landscape of the healthcare economy continues to evolve and advance, it’s clear as day that CBD is becoming an influential player in the future of medicine.
Human immunodeficiency virus or HIV for short has long been believed to be a death wish and thanks to advancements in the medical field over the years, that is no longer the case. HIV is a disease contracted by contact with infected blood, semen or vaginal fluid and attacks the body’s immune system. Treatment with HIV medicine is called antiretroviral therapy (“ART”) and patients take a plethora of HIV medicines on ART daily to treat the virus as efficiently as possible (1). Marijuana is another medicine that can be used to alleviate HIV symptoms and we’re going to shed some light on that avenue of care here.
HIV directly affects an individual’s ability to consume food due to anorexia, nausea etc., thus encouraging malnutrition and progressing the virus – which is something we don’t ever want. Smoked marijuana with a combination of 8 doses of dronabinol (cannabis) capsules daily implemented in a 16-day double-blind study, found that the group consuming both the smokable marijuana and dronabinol increased their caloric intake substantially (2). With boosted appetites, comes opportunities for vitamins and minerals to be passed into the body making THC’s hunger-inducing element a solid ally in this good fight. The marijuana in particular, also improved sleep ratings among restless HIV patients.
Neuropathic pain in HIV-infected individuals plague their condition of life, function and threshold of hope but cannabis can help diminish the detrimental in this aspect as well. Marijuana strains containing 1% to 8% THC potency, used in a 2008 study, revealed that cannabis delivered at least 30% of pain relief at four times daily smoked for 5 days consecutively to the using HIV patients involved (3). Pain wasn’t the only condition shown to be remedied; moods were enhanced as well and that is just as vital.
There is a difference between HIV and AIDS ladies and gentlemen. One of the most important differences is with the proper care and medication, HIV can be treated so well that it never gets the opportunity to develop into AIDS (acquired immunodeficiency syndrome). AIDS is the final stage of HIV and at this point, your CD4 cell (cells responsible for fighting infections) count is dangerously low. Be knowledgeable, be aware and speak with a medical professional for advice on cannabis use for your unique condition prior to any form of inclusion.
Cancer, seizures and HIV/AIDS symptoms – marijuana has proven to be a viable option for treatment use in all of these medical conditions. Another medical condition added to that list is Parkinson’s Disease (PD); the motor and non-motor symptoms of PD, to be specific. (1) Parkinson’s Disease is a neurodegenerative disorder that affects primarily dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. PD symptoms include slowness of movement (or “bradykinesia”), stiffness of the arms or legs, involuntary shaking (mainly at rest) and a few others.
(2) A 2011 to 2012 open-label observational study of 22 PD patients who were evaluated at both baseline and 30 minutes after smoking marijuana, produced magnificent results in favor of cannabis. The mean (SD) total score on the motor Unified Parkinson Disease Rating Scale showed significant improvement in those 22 patients post cannabis treatment, from 33.1 (13.8) at baseline to 23.2 (10.5) in terms treating their tremors, rigidity and bradykinesia. The study also revealed that the 22 PD patients, after smoking marijuana, experienced better quality of sleep and improved pain scores.
It’s absolutely amazing what this plant currently does and can do, for the medical field. The data found in this study helps individuals suffering from Parkinson’s Disease consider another method of treating their symptoms outside of Benztropine (anti-tremor drug) and Ropinirole. Marijuana provides an alternative to pills and tablets – one of its many traits.
We are in no way, shape or form encouraging any individuals to use this article to attempt to or validate self-medication. We strongly recommend everyone seek medical attention and consult with a medical professional prior to any type of treatment.
The unearthing study, titled “The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis” was received for review on March 10th, 2000, approved June 2nd, 2000 and published August 15th, 2000(1). This study highlighted the practice of CBD intake (both via injection and orally) to treat murine collagen-induced arthritis (CIA) to some degree.
The results of the study found that CBD stopped the progression of this arthritis through several ways; one of the ways being cannabinoids protecting the joints against serious ongoing damage. Arthritis affects the joints heavily, so this finding is extremely vital to the possibility of CBD becoming a routine remedy for a condition that over 3 million people in the US deal with yearly.
Another way CBD halted the advancement of the arthritis is by blocking the lipopolysaccharide-induced rise in the serum tumor factor. This is what jumps out to us – the cannabinoids combating harmful components on this level is what makes it such a breakthrough in the current wellness field.
The dosages used to stimulate optimal effects in reference to the benefits were 5mg/kg per day by injection or 25mg/kg per day orally. We recommend you get professional medical guidance on which method is safe and appropriate for you and your unique condition.
We are committed to shining more and more light on the topic of CBD, studies concerning cannabinoids and the medical trials of cannabis in entirety, so we thank you all for riding this wave with us!